Search hospitals > Texas > Bryan
Saint Joseph Regional Cancer Center
Claim this profileBryan, Texas 77802
Global Leader in Skin Cancer
Global Leader in Lung Cancer
Conducts research for Breast Cancer
Conducts research for Stomach Cancer
Conducts research for Breast cancer
164 reported clinical trials
2 medical researchers
Summary
Saint Joseph Regional Cancer Center is a medical facility located in Bryan, Texas. This center is recognized for care of Skin Cancer, Lung Cancer, Breast Cancer, Stomach Cancer, Breast cancer and other specialties. Saint Joseph Regional Cancer Center is involved with conducting 164 clinical trials across 353 conditions. There are 2 research doctors associated with this hospital, such as Richard L. Deming and Mehmet S. Copur.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Lung Cancer
Global LeaderStage IV
Stage II
Stage I
Top PIs
Richard L. DemingMercy Medical Center - Des Moines6 years of reported clinical research
Expert in Skin Cancer
Expert in Breast Cancer
178 reported clinical trials
242 drugs studied
Mehmet S. CopurBethesda North Hospital13 years of reported clinical research
Studies Breast Cancer
Studies Breast cancer
3 reported clinical trials
14 drugs studied
Clinical Trials running at Saint Joseph Regional Cancer Center
Breast Cancer
Bladder Cancer
Lung Cancer
Skin Cancer
Bladder Carcinoma
Multiple Myeloma
Testicular cancer
Breast cancer
Uterine Tumors
Kidney Cancer
Carvedilol
for Preventing Heart Problems in HER2 Positive Breast Cancer
This phase III trial studies how well carvedilol works in preventing cardiac toxicity in patients with human epidermal growth factor receptor (HER)-2-positive breast cancer that has spread to other places in the body. A beta-blocker, such as carvedilol, is used to treat heart failure and high blood pressure, and it may prevent the heart from side effects of chemotherapy.
Recruiting2 awards Phase 323 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Marker-Directed Monitoring
for Breast Cancer
This trial studies if using blood tests to decide when to do scans is as effective as the standard way for monitoring patients with a specific type of breast cancer that has spread. The blood tests act like an early warning system for cancer activity.
Recruiting1 award N/A
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Saint Joseph Regional Cancer Center?
Saint Joseph Regional Cancer Center is a medical facility located in Bryan, Texas. This center is recognized for care of Skin Cancer, Lung Cancer, Breast Cancer, Stomach Cancer, Breast cancer and other specialties. Saint Joseph Regional Cancer Center is involved with conducting 164 clinical trials across 353 conditions. There are 2 research doctors associated with this hospital, such as Richard L. Deming and Mehmet S. Copur.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.